# An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

> **NCT01281306** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 910 (actual)

## Conditions studied

- Systolic Hypertension

## Interventions

- **DRUG:** LCZ696
- **DRUG:** Valsartan
- **DRUG:** AHU377
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01281306
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 910 (ACTUAL)
- **Last updated:** 2016-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01281306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01281306, "An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01281306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*